We are live on
!
Find out more
RC
RegentAtlantic Capital Portfolio holdings
AUM
$3.34B
1-Year Est. Return
14.54%
This Fund
S&P 500
This Quarter
Est. Return
+10.13%
1 Year Est. Return
-14.54%
3 Year Est. Return
+23.47%
5 Year Est. Return
+45.3%
10 Year Est. Return
–
AUM
$1.04B
AUM Growth
+$118M
(+13%)
Cap. Flow
-$117M
Cap. Flow
% of AUM
-11.34%
Top 10 Holdings %
Top 10 Hldgs %
28.39%
Holding
366
New
27
Increased
101
Reduced
180
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KYTH
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
|
+$8.02M |
| 2 |
Goldman Sachs
GS
|
+$4.67M |
| 3 |
Citigroup
C
|
+$1.86M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$1.39M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShare MSCI Eurozone ETF
EZU
|
+$96.4M |
| 2 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$48.6M |
| 3 |
DELL
DELL INC
DELL
|
+$2.92M |
| 4 |
Cboe Global Markets
CBOE
|
+$822K |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$488K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.14% |
| 2 | Financials | 11.65% |
| 3 | Technology | 11% |
| 4 | Energy | 9.38% |
| 5 | Industrials | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STJ
151
DELISTED
St Jude Medical
STJ
| $1.33M | 0.13% |
21,493
-299
| -1% | -$17.3K |
|
152
AbbVie
ABBV
$454B
| $1.26M | 0.12% |
23,802
-283
| -1% | -$13.9K |
|
|
BHI
153
DELISTED
Baker Hughes
BHI
| $1.25M | 0.12% |
22,527
-826
| -4% | -$45.2K |
|
154
Domino's
DPZ
$11.4B
| $1.23M | 0.12% |
17,690
-1,550
| -8% | -$106K |
|
155
PepsiCo
PEP
$191B
| $1.19M | 0.12% |
14,346
-1,752
| -11% | -$145K |
|
|
FISV
156
Fiserv Inc
FISV
$27.9B
| $1.19M | 0.11% |
40,264
-2,800
| -7% | -$75.5K |
|
|
TEG
157
DELISTED
INTEGRYS ENERGY GROUP INC COM (USA)
TEG
| $1.19M | 0.11% |
21,833
-255
| -1% | -$14.3K |
|
158
Omnicom Group
OMC
$23.5B
| $1.19M | 0.11% |
15,953
-175
| -1% | -$12K |
|
159
iShares 0-5 Year TIPS Bond ETF
STIP
$15.9B
| $1.18M | 0.11% |
+11,671
| New | +$1.18M |
|
160
CSX Corp
CSX
$96B
| $1.17M | 0.11% |
122,127
+5,859
| +5% | +$52.5K |
|
161
iShares MSCI EAFE ETF
EFA
$76.8B
| $1.15M | 0.11% |
17,129
+9,927
| +138% | +$649K |
|
162
Sempra
SRE
$59.7B
| $1.15M | 0.11% |
25,542
-350
| -1% | -$15.5K |
|
163
iShares MSCI Emerging Markets ETF
EEM
$28.6B
| $1.14M | 0.11% |
27,367
+1,684
| +7% | +$70.5K |
|
164
Lincoln National
LNC
$7.88B
| $1.14M | 0.11% |
22,039
+4,445
| +25% | +$213K |
|
165
Cintas
CTAS
$84.4B
| $1.12M | 0.11% |
75,024
-780
| -1% | -$10.6K |
|
166
Xcel Energy
XEL
$50.4B
| $1.11M | 0.11% |
39,578
+9,172
| +30% | +$259K |
|
167
Whirlpool
WHR
$2.44B
| $1.06M | 0.1% |
6,775
+667
| +11% | +$97.8K |
|
168
Vanguard Short-Term Bond ETF
BSV
$44.6B
| $1.06M | 0.1% |
13,282
+3,740
| +39% | +$301K |
|
169
PPG Industries
PPG
$26.4B
| $1.06M | 0.1% |
11,172
| – | – |
|
170
Ameriprise Financial
AMP
$47.6B
| $1.06M | 0.1% |
9,177
-88
| -0.9% | -$9.09K |
|
171
Deere & Co
DE
$169B
| $1.05M | 0.1% |
11,538
-293
| -2% | -$24.8K |
|
|
RAI
172
DELISTED
Reynolds American Inc
RAI
| $1.05M | 0.1% |
42,004
-1,294
| -3% | -$32.6K |
|
173
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.3B
| $1.04M | 0.1% |
20,487
+10,158
| +98% | +$504K |
|
174
Alphabet (Google) Class C
GOOG
$3.99T
| $1.03M | 0.1% |
37,058
-241
| -0.6% | -$6.09K |
|
175
Vanguard FTSE Developed Markets ETF
VEA
$227B
| $1.02M | 0.1% |
+24,528
| New | +$995K |
|
Similar funds
5L
W
MA
APA
MIAN
CCM
AC
DY
RegentAtlantic Capital's Q4 2013 Portfolio in Review
As of Q4 2013, RegentAtlantic Capital held 366 positions worth $1.04B, up 13% from $917M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
RegentAtlantic Capital withdrew a net $117M in Q4 2013, closing 13 positions and reducing 180 holdings. Its most notable exit was iShare MSCI Eurozone ETF, an estimated $96.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 12% a quarter earlier, followed by Financials and Technology.
Against the trend, RegentAtlantic Capital opened a new position in KYTHERA BIOPHARMACEUTICALS, INC COM worth $7.23M.
- RegentAtlantic Capital's largest Q4 2013 buy was KYTHERA BIOPHARMACEUTICALS, INC COM: 193,454 shares worth $7.23M.
- RegentAtlantic Capital added most to Goldman Sachs in Q4 2013, an estimated $4.67M increase.
- RegentAtlantic Capital's biggest Q4 2013 reduction was Cboe Global Markets, cutting an estimated $822K.
- RegentAtlantic Capital fully exited iShare MSCI Eurozone ETF in Q4 2013, selling an estimated $96.4M.
- RegentAtlantic Capital's ten largest holdings make up 28% of its $1.04B portfolio in Q4 2013.
- RegentAtlantic Capital opened 27 new positions and closed 13 in Q4 2013.
- RegentAtlantic Capital's portfolio value rose 13% quarter-over-quarter to $1.04B.
Based on RegentAtlantic Capital's 13F filing for Q4 2013, filed 31 Jan 2014.